Aura Biosciences Inc (AURA)

Apr 18, 2025

Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com

Apr 18, 2025

Apr 18, 2025

Vanguard Group Inc. Acquires 112,296 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Apr 18, 2025

Apr 17, 2025

Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock By Investing.com - Investing.com Canada

Apr 17, 2025

Apr 16, 2025

Aura Biosciences executive sells $39,319 in stock By Investing.com - Investing.com Canada

Apr 16, 2025

Apr 16, 2025

Aura Biosciences executive sells $39,319 in stock - Investing.com

Apr 16, 2025

Apr 16, 2025

Aura Biosciences SVP sells $4,924 in stock - Investing.com

Apr 16, 2025

Apr 16, 2025

Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock - Investing.com

Apr 16, 2025

Apr 14, 2025

Wellington Management Group LLP Has $1.08 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Apr 14, 2025

Apr 13, 2025

American Century Companies Inc. Has $392,000 Stake in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Apr 13, 2025

Apr 12, 2025

Q1 EPS Estimate for Aura Biosciences Decreased by Analyst - Defense World

Apr 12, 2025

Apr 11, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 11, 2025

Apr 10, 2025

Aura Biosciences stock hits 52-week low at $5.05 - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

Aura Biosciences stock hits 52-week low at $5.05 By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 06, 2025

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential? - Insider Monkey

Apr 06, 2025

Apr 02, 2025

Aura Biosciences expands board with oncology leader By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 02, 2025

Aura Biosciences Appoints Teresa Bitetti To Board - citybiz

Apr 02, 2025

Apr 02, 2025

Aura Biosciences Announces Appointment Of Teresa Bitetti To Board Of Directors - MarketScreener

Apr 02, 2025

Apr 02, 2025

Aura Biosciences Expands Board with New Director Appointment - TipRanks

Apr 02, 2025

Apr 02, 2025

Aura Biosciences expands board with oncology leader - Investing.com

Apr 02, 2025

Apr 02, 2025

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - GlobeNewswire

Apr 02, 2025

Mar 31, 2025

Aura Biosciences stock hits 52-week low at $5.75 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Aura Biosciences stock hits 52-week low at $5.75 amid market challenges - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Are Investors Keen On Selling Holdings In Aura Biosciences Inc (NASDAQ: AURA)? - stocksregister.com

Mar 31, 2025

Mar 29, 2025

(AURA) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 29, 2025

Mar 28, 2025

Q1 Earnings Estimate for AURA Issued By HC Wainwright - Defense World

Mar 28, 2025

Mar 27, 2025

Aura Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Mar 27, 2025

Institutional investors may adopt severe steps after Aura Biosciences, Inc.'s (NASDAQ:AURA) latest 20% drop adds to a year losses - Simply Wall St

Mar 27, 2025

Mar 27, 2025

Aura Biosciences Inc: Promising Clinical Progress and Financial Stability Justify Buy Rating - TipRanks

Mar 27, 2025

Mar 27, 2025

What is HC Wainwright’s Forecast for AURA Q3 Earnings? - Defense World

Mar 27, 2025

Mar 27, 2025

Aura Biosciences Stock (AURA) Continues to Slide Despite Promising Clinical Progress - markets.businessinsider.com

Mar 27, 2025

Mar 26, 2025

Aura Biosciences price target lowered to $19 from $21 at Citizens JMP - TipRanks

Mar 26, 2025

Mar 26, 2025

Character Biosciences gains $93m for precision eye disease therapies - Pharmaceutical Technology

Mar 26, 2025

Mar 26, 2025

Bel-sar shows promising safety, efficacy in NMIBC - Urology Times

Mar 26, 2025

Mar 26, 2025

Aura Biosciences stock target cut to $19 by JMP Securities - Investing.com UK

Mar 26, 2025

Mar 26, 2025

Aura Biosciences Reports Progress in Cancer Trials - TipRanks

Mar 26, 2025

Mar 25, 2025

Aura Biosciences Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

Mar 25, 2025

Mar 25, 2025

Aura Biosciences stock target raised to $25 by H.C. Wainwright - Investing.com UK

Mar 25, 2025

Mar 25, 2025

Promising Clinical Data and Abscopal Effect Drive Buy Rating for Aura Biosciences Inc. - TipRanks

Mar 25, 2025

Mar 24, 2025

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewswire

Mar 24, 2025

Mar 24, 2025

Aura Biosciences Reports Positive Phase 1 Trial Results in Non-Muscle Invasive Bladder Cancer and Advances Clinical Pipeline - Nasdaq

Mar 24, 2025

Mar 24, 2025

Aura's Cancer Drug Delivers Complete Responses as $151M Cash Runway Extends to 2026 - Stock Titan

Mar 24, 2025

Mar 24, 2025

Promising Phase 1 Results for Aura Biosciences’ Bel-sar in Bladder Cancer Boost Buy Rating - TipRanks

Mar 24, 2025

Mar 24, 2025

Aura reports promising bladder cancer trial results By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Aura Biosciences stock hits 52-week low at $6.58 amid market shifts - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Buy Recommendation for Aura Biosciences: Promising Phase 1 Trial Results and Dual Mechanism of Action in Bladder Cancer Treatment - TipRanks

Mar 24, 2025

Mar 24, 2025

Aura Biosciences stock hits 52-week low at $6.58 amid market shifts By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Buy Rating for Aura Biosciences Inc. Driven by Promising Phase 1 Trial Results and Future Revenue Potential - TipRanks

Mar 24, 2025